Skip to main content

Video Library

Leading transplant experts share vital information to help you make informed healthcare decisions before and after transplant.

Astronauts, Transplant and CAR T-cell Recipients: What Do They Have In Common?

Strategies astronauts use to stay fit during space flight can help bone marrow/stem cell transplant and CAR T-cell recipients.
Categories
Tags
Graft-versus-host disease commonly affects the the gastrointestinal tract and /or liver in patients who have had an stem cell transplant using cells from a donor (allogeneic transplant). Treatment may require a combination of local therapies, systemic therapies, procedural interventions and/or various types of supportive care.
Chronic fatigue is a common complaint after a stem cell transplant. Learn what causes it and strategies you can use to manage it.
Learn about proper nutrition for recovering transplant recipients and common myths about popular diets.
20% of patients experience breathing problems 100+ days after transplant. Pulmonary function tests can help determine the cause of the problem and define treatment options.
Twenty percent of cancer survivors report limitations on their ability to work one to five years after diagnosis. Disability laws requires employers, in many cases, to make reasonable accommodations to a person’s job, schedule, or workplace environment to enable the person to continue to work.
The physical and emotional needs of caregivers for stem cell transplant recipients are often unaddressed, as the medical team focuses on the needs of the patient. Caregivers need to identify strategies that will help them manage chronic stress for the long-haul.
Sexual health is often affected by transplant, but is seldom discussed by patients and physicians. This presentation describes common sexual difficulties women experience after transplant and strategies to manage them.
Graft-versus-host disease in the mouth (oral GVHD) is very common after transplant and manifests itself in many different ways. Treatments are available to manage the discomfort caused by oral GVHD.
CAR T-cell therapy is a new type of immunotherapy that’s been approved by the FDA to treat patients with certain types of leukemia and lymphoma. Some patients have lived more than 10 years after treatment.
Evaluates the risks for developing neuropathy after transplant, and strategies to manage the weakness and pain associated with neuropathy.
The current standard of care for patients with multiple myeloma is high dose chemotherapy and an autologous stem cell transplant. Although an autologous transplant is not a cure, maintenance therapy with various drugs can control myeloma in many patients for several years.
Health insurance may be available to you through an employer, association, Medicaid, Medicare or an Affordable Care Act marketplace. A variety of legal protections are available to healthcare consumers under Federal and State laws.
mature african woman talking over phone

One-on-One Peer Support

Talk to someone who has been a transplant or CAR T-cell patient or their caregiver. Get ideas to help you through treatment.

GVHD Support Groups

Join a Support Group

Join a private online support group for patients or caregivers living with chronic graft-versus-host disease (GVHD). Groups are also available for people who have received CAR T-cell therapy.

Mental Health Directory

Find a Mental Health Provider

Find a mental health provider who understands what's involved in undergoing a transplant or CAR T-cell therapy or living with graft-versus-host disease (GVHD).